Measurement of the fragmentation of Carbon nuclei used in hadron-therapy
β Scribed by G. De Lellis; S. Buontempo; F. Di Capua; A. Di Crescenzo; P. Migliozzi; Y. Petukhov; C. Pistillo; A. Russo; P. Strolin; V. Tioukov; M. Durante; Y. Furusawa; T. Toshito; N. Yasuda; A. Ariga; N. Naganawa
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 243 KB
- Volume
- 853
- Category
- Article
- ISSN
- 0375-9474
No coin nor oath required. For personal study only.
β¦ Synopsis
The increasing use of Carbon nuclei in cancer therapy centres is motivated by their potential advantages as a very precise high LET radiation. The knowledge of the fragmentation of Carbon nuclei when they interact with the human body is important to evaluate the spatial profile of their energy deposition in the tissues, hence the damage to the tissues neighbouring the tumour. We report here a study of the fragmentation with the nuclear emulsion experimental technique. We have designed, built and exposed to a Carbon nuclei beam a chamber made of Lexan plates alternated with nuclear emulsion films. Lexan plates acted as passive material simulating human body tissues while nuclear emulsion films were used as both tracking devices with micrometric accuracy and ionisation detectors. Such a detector allowed the detection of Carbon interactions produced along their path, the identification of the fragments produced and the measurement of
π SIMILAR VOLUMES
The fine segmented hadron calorimeter of the KASCADE experiment allows to study the hadronic component of extensive air showers. Several hadronic observables are compared with predictions of air shower simulations, using Lhe interaction models VENUS, QGSJET and SIBYLL with the objective to test the
The longitudinal momentum distributions of 34 neutron-rich isotopes of elements produced by fragmentation of a 76 Ge beam at 132 MeV/u with 13 r Z r 27 were scanned using a novel experimental approach where a variety of targets with different thicknesses was used with the fragment separator at const
## Abstract Myocarditis is one of the most commonly cardiovascular diseases in clinical practice, but the treatment is always limited at present. Considering the multifactorial etiology of myocarditis, a novel therapeutic agent with multiβbioactivties should be presented. Red wine has been recogniz